The present application discloses novel benzimidazole derivatives of general formula (I) or an N-oxide thereof, any of its stereoisomers or any mixture of its stereoisomers, or a pharmaceutically acceptable salt thereof, wherein Ra, Rb and Rc independent of each other represents hydrogen or alkyl; and Rd represents a pyridyl group; which pyridyl group is optionally substituted with one or more substituents independently selected from the group consisting of: halo, trifluoromethyl, trifluoromethoxy, cyano, nitro, alkyl, hydroxy, hydroxyalkyl and alkoxy, and their use as modulators of the GABAA receptor complex. In other aspects the application discloses the use of these compounds, in a method for therapy and to pharmaceutical compositions comprising these compounds.
本申请公开了一种新型
苯并咪唑衍
生物的一般结构式(I)或其N-氧化物,其立体异构体中的任何一种或其立体异构体的任何混合物,或其药学上可接受的盐,其中Ra、Rb和Rc分别独立地代表氢或烷基;Rd代表
吡啶基;所述
吡啶基可以选择地与来自以下组的一个或多个取代基独立地取代:卤素、三
氟甲基、三
氟甲氧基、
氰基、硝基、烷基、羟基、羟基烷基和烷氧基,并且其用作
GABAA受体复合物的调节剂。在其他方面,本申请公开了这些化合物的用途,包括治疗方法和包含这些化合物的药物组合物。